Our previous study has found the anti-tumor activity of oleandrin in osteosarcoma cells in vitro, but the signal transduction process of cell apoptosis induced by oleandrin is uncertain, which is explored in this study. Fluorescence staining and flow cytometry (FCM) was performed to detect the cell apoptosis, intracellular reactive oxygen species (ROS) and mitochondrial membrane potential (MMP). Caspase-3 activity was detected using a commercial kit. The protein expression of cytoplasmic cytochrome c, mitochondrial cytochrome c, bcl-2, bax, caspase-9, Fas, FasL, caspase-8 and caspase-3 was detected using western blot. A pan-caspase inhibitor, z-VAD-fmk, was applied to block the apoptotic pathway and the apoptosis status were re-tested. We found that oleandrin significantly induced the increased apoptosis of U2OS cells. Meanwhile, the intracellular ROS was elevated, but the MMP decreased. The cytochrome c in mitochondria was notably decreased but increased in cytoplasm. The caspase-3 activity was also enhanced with the increase of drug concentration and treatment time. Oleandrin also down-regulated the level of bcl-2, but remarkably upregulated the expression of bax, cleaved caspase-9, Fas, FasL, cleaved caspase-8 and cleaved caspase-3. Furthermore, the pre-treatment with z-VAD-fmk almost completely reverted the oleandrin-induced apoptosis. The results suggested that oleandrin induces the apoptosis of osteosarcoma cells via mitochondrial-and death receptor-dependent pathways.
Introduction
Oleandrin, a polyphenolic component of cardiac glycosides, has been reported recently to play an anti-tumor effect on many kinds of tumor cells. Considerable evidences have suggested that oleandrin is a perfect agent for tumor chemotherapy due to its selective cytotoxicity and chemoradiation-sensitization [1] [2] [3] [4] . Recently, the result of a clinical Phase I trial suggested that it may become a new antitumor drug for the treatment of patients with refractory solid tumors [5] . The anti-tumor effect of oleandrin involves in the regulation of diverse molecular biology processes, including inhibition of nuclear factor kappa B (NF-κB) / c-Jun NH2-terminal kinase (JNK) signaling pathway [6] , activation of death receptor / Apo2L / TRAIL apoptosis signaling pathway [7] , suppression of interaction between fibroblast growth factor-2 (FGF-2) and Na + , K + -ATPase pump [8] , induction of intracellular reactive oxygen species production [9] , and stimulation of intracellular Ca 2+ increases and activation of caspase cascade apoptotic signals [10] .
Osteosarcoma is still an intractable bone malignance with high mortality due to the frequent recurrence, early metastasis and chemotherapeutic toxicity, even though the improvement of modified surgical techniques and novel chemotherapies has reduced patients' mortality to a certain extent [11, 12] . The heterogeneity and the genomic complexity also challenge its chemotherapy and molecular targeted therapy [11] . Thus, it is of importance to identify a novel agent with selective cytotoxicity to osteosarcoma cells.
Our previous study has identified the anti-proliferation and anti-invasion effect of oleandrin in osteosarcoma cells, which reveals that its potential value in the osteosarcoma treatment [13] . Meanwhile, we have also observed that oleandrin can modulate the expression of certain apoptosis-related genes including c-myc, cyclin D1 and survivin, which ultimately promotes cells apoptosis through enhancing signal transduction pathway of cell apoptosis [13] [14] [15] . However, the detailed signal transduction mechanism of cell apoptosis induced by oleandrin in osteosarcoma is still uncertain. So, we focus on exploring these issues in current study.
Results

Oleandrin induces the apoptosis of U2OS cells
Both DAPI and Hoechst 33342 staining indicated that cell nuclei presented an uneven morphology and appeared obvious pyknosis or even karyolysis in response to oleandrin with the increase of treatment time, which revealed a typical characteristics of cell apoptosis ( Figure   1a ). In addition, the flow cytometry (FCM) analysis also showed that different concentration of oleandrin induced cell apoptosis (Figure 1b) , and the total apoptosis rate significantly increased from 7.13 ± 1.78 % (control) to 15.47 ± 2.04 % (25nM, P < 0.01), and to 21.97 ± 2.10 % (50 nM, P < 0.001) (Figure 1c) .
Oleandrin causes the generation of intracellular reactive oxygen species (ROS)
ROS generation is one of the hallmarks of cell apoptosis. The intracellular ROS level in response to incubation with oleandrin was observed under a fluorescence microscope and also detected using FCM. The result of fluorescence staining demonstrated that cells treated with 25 and 50 nM oleandrin presenting a significant increase of intracellular ROS (represented by green fluorescence) in U2OS cells when compared with the control group (Figure 1d) . The result of FCM also verified that oleandrin increased ROS level to nearly 1.5-fold at 25 nM (P < 0.05) and 2.0-fold at 50 nM (P < 0.01) when compared with the control group (Figure 1e) . 
Oleandrin decreases intracellular mitochondrial membrane potential (MMP) level
The intracellular MMP level is determined using FCM and the result was represented by the FITC-A (green) / PE-A (red) ratio. Actually, the intracellular MMP level is negatively correlated with FITC-A / PE-A ratio, so the increase of this ratio represented a descending MMP level and the occurrence of apoptosis. Our result suggested that the FITC-A / PE-A ratio was gradually increased with oleandrin treatment in a concentration-dependent manner, and the significance was observed in 50 nM oleandrin-treated group (P < 0.001) (Figure 2a) .
Oleandrin induces cytochrome c released from mitochondria to cytoplasm
After treating with oleandrin for different time, the cytochrome c was down-regulated in mitochondria, but up-regulated in cytoplasm (Figure 2b) . Compared with the 0 h group, the cytoplasmic cytochrome c in U2OS cells gradually increased and the significance was occurred at 48 h (P < 0.05). On the contrary, the mitochondrial cytochrome c remarkably reduced after treating for 24 h (P < 0.01) and 48 h (P < 0.001) (Figure 2c ).
Oleandrin enhances caspase-3 activity
Oleandrin significantly increased caspase-3 activity in a concentration-and timedependent manner. Compared to the control group, caspase-3 activity was gradually enhanced with increasing concentration of oleandrin, and the significance was observed in the 50 nM group (P < 0.001) (Figure 2d) . Similarly, the activity also increased to about 2.5 times after the treatment of 50nM oleandrin for 24 h (P < 0.05) and 4.0 times for 48 h (P < 0.001), respectively (e) Caspase-3 activity with the extension of treatment time; n = 3, Mean ± SD; *P < 0.05, **P < 0.01, ***P < 0.001, compared to the control group or the 0 h group.
Oleandrin regulates apoptosis-related proteins in mitochondrial-and death receptor-dependent apoptotic pathways
The results of western blot indicated that oleandrin significantly up-regulated the expression of proteins including bax, cleaved caspase-9, Fas, FasL, cleaved caspase-8 and cleaved caspase-3. However, the expression of bcl-2, an anti-apoptotic molecule, was downregulated along with incubation time (Figure 3a) . In addition, the semi-quantitative analysis also suggested that the levels of bax / bcl-2 ratio, cleaved caspase-9, Fas, FasL, cleaved caspase-8, and cleaved caspase-3 were significantly elevated (Figure 3b, c) . Semi-quantitative analysis of the bax / bcl-2 ratio; (c) Semiquantitative analysis of the proteins including Fas, FasL, caspase-9, caspase-8 and caspase-3; n = 3, Mean ± SD; *P < 0.05, **P < 0.01, ***P < 0.001, compared to the 0 h group.
The pro-apoptosis effect of oleandrin is mitochondrial-and death receptor-dependence
In order to confirm the pro-apoptotic effect of oleandrin was mitochondrial-and death receptor-dependence, furthermore, we pretreated cells with a pan-caspase inhibitor named z-VAD-fmk to suppress caspases cascade activation in both pathways and re-tested the proapoptotic effect of oleandrin. The results showed that pro-apoptotic effect of oleandrin was significantly restrained when both pathways were suppressed by z-VAD-fmk. The number of pyknotic or karyolysic nuclei in apoptosis cells descended both in the DAPI and Hoechst 33342 staining with the addition of z-VAD-fmk (Figure 4a) . Likewise, the number of apoptotic cells (Figure 4b ) and total apoptosis rates (Figure 4c) were also nearly reduced to normal level in this group (P < 0.001). 
Discussion
Our previous study has identified that oleandrin has antitumor effect on osteosarcoma cells and regulates the expression of certain apoptosis-related genes [13] . However, the following signal transduction process of apoptosis induced by oleandrin in osteosarcoma is still unclear. In this study, we re-confirmed that oleandrin-treated cells presented a typical apoptotic morphology with obvious nuclei pyknosis or karyolysis and the cell apoptosis rate was remarkably increased. Besides, we also explored the detailed apoptosis regulation of oleandrin in osteosarcoma cells.
Actually, many studies have reported the pro-apoptotic function of oleandrin in various human tumors through the regulation of apoptosis-associated signaling pathways [1, 4, 9, 16] .
It is well known that there are two mainly apoptotic signaling pathways: the mitochondria (intrinsic) and death receptor (extrinsic) pathways [17] .
In the mitochondria-associated apoptosis pathway, B-cell lymphoma 2 (bcl-2) family proteins including the anti-apoptotic proteins (bcl-2 and bcl-xl) and the pro-apoptotic proteins (bax, bak, bad and bim), are primary molecules of the up-stream that respond to apoptosis signals. A decrease of the bax / bcl-2 ratio is commonly observed in various tumors, and closely correlated to the inhibition of cell apoptosis, insusceptibility to undergo apoptosis, tumor recurrence and patients' poor prognosis [18, 19] . These proteins are mostly localized to the mitochondrial membrane and involve in the mediation of mitochondrial membrane function.
Mitochondria are the crucial production sites of ROS, which regulates the intracellular redox status. Physiologically, low concentration of ROS can be used as the second messenger to participate in multiple signaling pathways to maintain homeostasis. When cells are stimulated by apoptosis signals, the aforementioned apoptosis-associated proteins rapidly react to the stress and induce ROS generation dramatically [20] . Meanwhile, high concentration of ROS in mitochondria may reduce the MMP that enhances the mitochondrial permeability, and induces certain mitochondrial factors (such as cytochrome c) released from mitochondria to cytoplasm [20, 21] . In cytoplasm, cytochrome c involves in the formation of cytochrome c / Apaf-1 / caspase-9-containing apoptosome, which subsequently result in the activation of caspase-9 and caspases-3 [21] . Caspases, the cytoplasmic aspartate-specific cysteinic proteases, play a central role in cell apoptosis to transfer apoptosis signals and their cascade activation is the hallmarker of apoptosis [22] . Caspase-3, serves as the final performer, leads to the degradation of the cellular specific substrates and induces cells apoptosis.
Our results showed that oleandrin significantly up-regulated the bax expression but down-regulated the bcl-2 level with the extension of treatment, which caused a significant increase of bax / bcl-2 ratio. In addition, the intracellular ROS level of oleandrin-treated U2OS cells was also substantially elevated in a concentration-dependent manner. However, the intracellular MMP level presented a decreasing trend according to the result of an increase of the FITC-A / PE-A ratio with drug concentration. Furthermore, we determined the levels of cytoplasmic and mitochondrial cytochrome c by separating the cytoplasmic and mitochondrial proteins. The results demonstrated that oleandrin treatment resulted in an intensive downregulation of the mitochondrial cytochrome c, but a strong up-regulation of the cytoplasmic cytochrome c, which suggested that oleandrin could induce the cytochrome c released from mitochondria to cytoplasm. Besides, oleandrin treatment also caused the increased expression of cleaved caspase-9 and cleaved caspase-3, and simultaneously enhanced the caspase-3 activity in a time-and concentration-dependence. These evidences revealed that oleandrin initiated the activation of mitochondria-dependent apoptosis pathway in U2OS cells through the up-regulation of pro-apoptosis protein bax and the down-regulation of anti-apoptosis protein bcl-2. And then, the extensive generation of intracellular ROS and the reduction of MMP level were also induced by oleandrin and lead to the release of cytochrome c from mitochondria to cytoplasm. Thus, caspase cascade reaction including the activation of caspase-9 and caspase-3 was initiated, which ultimately led to the occurrence of cells apoptosis.
In the death receptor-associated apoptosis pathway, the death-inducing signaling complex (DISC) including the tumor necrosis factor (TNF) receptor, TNF-related apoptosis-inducing ligand (TRAIL) receptors, Fas and FasL, can be triggered by apoptotic signals and drive the activation of caspase-8 [23] . Activated caspase-8 can transduce apoptosis signal to the downstream through directly cleaving caspase-3 or indirectly cleaving Bid to tBid, which further translocate to the mitochondrial membranes and induce the membrane permeabilization [23, 24] . As well, these events eventually cause the occurrence of apoptosis.
Likewise, we also determined the expression of Fas, FasL and cleaved caspase-8 were all significantly increased after incubating with oleandrin for different time. These results demonstrated that oleandrin also prompted the activation of death receptor apoptosis pathway through up-regulating the expression of death receptor Fas and its ligand FasL, and inducing caspase cascade reaction with the activation of caspase-8.
Furthermore, z-VAD-fmk, a pan-caspase inhibitor, was also applied to test whether the oleadrin-induced apoptosis was exactly a mitochondrial-and death receptor-dependence. z-VAD-fmk induces caspase-3 alkylation and blocks its activity, which results in the inactivation of caspase cascade reaction both in mitochondria-and death receptor-dependent apoptosis pathways [25] . The result of fluorescence stain indicated that a decreasing cell number with nuclei pyknosis and karyolysis was found in the oleandrin combined with z-VAD-fmk group.
What's more, the total apoptosis rate of U2OS cells with the z-VAD-fmk pre-treatment was significantly lower than oleandrin group and also nearly reverted to the normal level. These findings illustrated that z-VAD-fmk could weaken the apoptosis induced by oleandrin and the oleandrin-induced apoptosis is associated with the caspases cascade activation in both mitochondrial and death receptor apoptosis pathways. contained with 1 % penicillin-streptomycin (10,000 U/mL) (Gibco, Grand Island, NY) and 10 % fetal bovine serum (FBS) (Gibco, Grand Island, NY), and maintained at 37 °C in a humidified 5 % CO2 incubator.
Materials and Methods
Drug preparation
DAPI and Hoechst 33342 staining
Cells were incubated within 24-well plates and under the treatment of 50 nM oleandrin for various time (0, 24 and 48 h). DAPI staining (Beyotime Biotechnology, Nanjing, China) was applied in 4 % paraformaldehyde fixed cells following membrane perforation with Triton X-100. Hoechst 33342 staining (Beyotime Biotechnology, Nanjing, China) was performed in live cells directly according to the protocol. The morphological change of cell nuclei was observed using a fluorescence microscope (Leica DM3000, Frankfurt, Germany).
Annexin V-FITC/PI apoptosis assay
Cell apoptosis was detected using an Annexin V-FITC/PI apoptosis detection kit (BioVision, California, USA) according to the manufacturer's protocol. Briefly, cells were seeded into 6-well plates and incubated with different concentration of oleandrin (0, 25 and 50 nM) for 24 h. After that, cells were collected and stained with Annexin V-FITC and PI. Then, they were immediately uploaded on a BD Accuri ® C6 flow cytometer (BD Biosciences, New Jersey, USA) to detect the fluorescence intensity of cells. The experiments were repeated three times and the total apoptosis rate was analyzed.
Intracellular ROS assay
After the treatment with various concentration of oleandrin, cells were washed with PBS and incubated with 100 μl PBS containing 10 μm DCFH-DA in the incubator for 30 min according to the protocol. The intracellular ROS level was detected using Reactive Oxygen Species Assay Kit (Beyotime Biotechnology, Beijing, China). The result was observed under fluorescence microscope and also analyzed with FCM. Before using fluorescence microscope to observe cells, cell nuclei were also stained with Hoechst 33342. The experiment was performed in triplicate for each group.
Mitochondrial membrane potential (MMP) assay
The changes of intracellular MMP after the oleandrin treatment were determined with a In healthy cells, JC-1 was selectively accumulated in the intact mitochondria to form multimer J-aggregates that emitting at 590 nm (PE-A, red fluorescence), but in apoptotic cells JC-1 enters the cytoplasm as a monomer, emitting at 527 nm (FITC-A, green fluorescence). The result was detected and analyzed using FCM. The increase of FITC-A (green) / PE-A (red) ratio was represented the occurrence of cell apoptosis. The experiment was repeated three times.
Caspase-3 activity assay
The oleandrin-treated cells were digested by trypsin and thoroughly lysed on ice for 30 min accompanied by vortexing every 10 min. The concentration of protein was detected using a BCA Protein Assay Kit according to the protocol (Applygen Technologies Inc., Beijing, China).
A total 150 μg protein was detected using a Caspase-3 Colorimetric Assay kit (Beyotime, Biotechnology, Beijing, China) and the absorption at 405 nm was determined using an Thermo Scientific TM automatic ELISA microplate reader (Thermo Fisher Scientific Inc., Waltham, MA, USA). The caspase-3 activity was represented by the ratio of OD405 (experiment group) / OD405 (control group). The assay was performed three times. 
Western blot assay
Statistical analysis
All data were analyzed with IBM SPSS statistics 20.0 software and represented as the mean ± standard deviation (SD). For the comparisons with the control group, statistical analyses were performed using one-way analysis of variance (ANOVA) with post hoc Dunnet analysis.
Pairwise comparison was applied using ANOVA with post hoc Tukey's test. A value of P < 0.05 was considered statistically significant.
Conclusions
Based on the results above, we can conclude that oleandrin induces the apoptosis of osteosarcoma cells via the activation of mitochondrial apoptosis pathway and death receptor pathway, and also induces the caspases cascade in both apoptosis pathways.
